119 related articles for article (PubMed ID: 37712672)
1. Potential Drug Interactions in Terminally-Ill Cancer Patients, a Report from the Middle East.
Mahzoni H; Naghsh E; Sharifi M; Moghaddas A; Momenzadeh M; Moghaddas A
J Pain Palliat Care Pharmacother; 2023 Dec; 37(4):278-285. PubMed ID: 37712672
[TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug Interactions in hospitalized cancer patients: A report from the Middle-East.
Moghaddas A; Adib-Majlesi M; Sabzghabaee AM; Hajigholami A; Riechelmann R
J Oncol Pharm Pract; 2021 Jan; 27(1):46-53. PubMed ID: 32183585
[TBL] [Abstract][Full Text] [Related]
3. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study.
Tavousi F; Sadeghi A; Darakhshandeh A; Moghaddas A
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e146-e151. PubMed ID: 30531601
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of drug-drug interactions in cancer therapy and the clinical outcomes.
Alnaim LS; Almalki HM; Almutairi AM; Salamah HJ
Life Sci; 2022 Dec; 310():121071. PubMed ID: 36243121
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance.
Hulskotte LMG; Töpfer W; Reyners AKL; Taxis K; Jansman FGA
Eur J Clin Pharmacol; 2024 Mar; 80(3):455-464. PubMed ID: 38217692
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
Laban AA; Birand N; Chukwunyere U; Abdi A; Basgut B
Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
[TBL] [Abstract][Full Text] [Related]
7. Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting.
Moradi O; Karimzadeh I; Davani-Davari D; Shafiekhani M; Sagheb MM; Raees-Jalali GA
Int J Organ Transplant Med; 2020; 11(4):185-195. PubMed ID: 33335699
[TBL] [Abstract][Full Text] [Related]
8. Potential drug-drug interactions in a medical intensive care unit of a university hospital.
Gülçebi İdriz Oğlu M; Küçükibrahimoğlu E; Karaalp A; Sarikaya Ö; Demirkapu M; Onat F; Gören MZ
Turk J Med Sci; 2016 Apr; 46(3):812-9. PubMed ID: 27513261
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
10. Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda.
Luzze B; Atwiine B; Lugobe HM; Yadesa TM
BMC Cancer; 2022 Dec; 22(1):1266. PubMed ID: 36471270
[TBL] [Abstract][Full Text] [Related]
11. Incidence of potential drug-drug interactions with antidiabetic drugs.
Samardzic I; Bacic-Vrca V
Pharmazie; 2015 Jun; 70(6):410-5. PubMed ID: 26189304
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
14. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
Preskorn SH; Shah R; Neff M; Golbeck AL; Choi J
J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
Guastaldi RB; Reis AM; Figueras A; Secoli SR
Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved.
Smithburger PL; Kane-Gill SL; Seybert AL
Int J Pharm Pract; 2012 Dec; 20(6):402-8. PubMed ID: 23134100
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study.
Kawabata M; Kaneishi K
Am J Hosp Palliat Care; 2013 May; 30(3):305-11. PubMed ID: 22669937
[TBL] [Abstract][Full Text] [Related]
20. The impact of drug interactions on adverse effects of oral oxycodone in male geriatric patients.
Kim JH; Kim JY; Lee N; Yee J; Gwak HS
J Clin Pharm Ther; 2020 Oct; 45(5):976-982. PubMed ID: 32068910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
